AMERICAN STRATEGIC INVESTM-A (NYC) Stock Fundamental Analysis

NYSE:NYC • US6494393043

8.75 USD
-0.06 (-0.68%)
Last: Feb 23, 2026, 10:17 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

Overall NYC gets a fundamental rating of 0 out of 10. We evaluated NYC against 62 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NYC have multiple concerns. NYC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • NYC had negative earnings in the past year.
  • In the past year NYC has reported a negative cash flow from operations.
  • NYC had negative earnings in each of the past 5 years.
  • NYC had a negative operating cash flow in each of the past 5 years.
NYC Yearly Net Income VS EBIT VS OCF VS FCFNYC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.72%, NYC is doing worse than 62.90% of the companies in the same industry.
  • The Return On Equity of NYC (-29.63%) is worse than 67.74% of its industry peers.
Industry RankSector Rank
ROA -4.72%
ROE -29.63%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
NYC Yearly ROA, ROE, ROICNYC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • NYC has a Gross Margin (24.71%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of NYC has declined.
  • The Profit Margin and Operating Margin are not available for NYC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
NYC Yearly Profit, Operating, Gross MarginsNYC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NYC has been increased compared to 1 year ago.
  • The number of shares outstanding for NYC has been increased compared to 5 years ago.
  • The debt/assets ratio for NYC is higher compared to a year ago.
NYC Yearly Shares OutstandingNYC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NYC Yearly Total Debt VS Total AssetsNYC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • NYC has an Altman-Z score of -2.00. This is a bad value and indicates that NYC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NYC (-2.00) is worse than 79.03% of its industry peers.
  • NYC has a Debt/Equity ratio of 4.88. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 4.88, NYC is doing worse than 82.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.88
Debt/FCF N/A
Altman-Z -2
ROIC/WACCN/A
WACC4.63%
NYC Yearly LT Debt VS Equity VS FCFNYC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that NYC may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.91, NYC is doing worse than 77.42% of the companies in the same industry.
  • NYC has a Quick Ratio of 0.91. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of NYC (0.91) is worse than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
NYC Yearly Current Assets VS Current LiabilitesNYC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • NYC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.73%, which is quite impressive.
  • Looking at the last year, NYC shows a very negative growth in Revenue. The Revenue has decreased by -16.71% in the last year.
  • The Revenue has been decreasing by -2.68% on average over the past years.
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%

3.2 Future

  • NYC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.45% yearly.
  • NYC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.40% yearly.
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NYC Yearly Revenue VS EstimatesNYC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
NYC Yearly EPS VS EstimatesNYC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 2026 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NYC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NYC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYC Price Earnings VS Forward Price EarningsNYC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 138.87
NYC Per share dataNYC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NYC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMERICAN STRATEGIC INVESTM-A

NYSE:NYC (2/23/2026, 10:17:23 AM)

8.75

-0.06 (-0.68%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-19
Earnings (Next)03-12
Inst Owners2.23%
Inst Owner Change-10.28%
Ins Owners5.41%
Ins Owner Change0%
Market Cap23.36M
Revenue(TTM)51.69M
Net Income(TTM)-21.15M
Analysts45
Price TargetN/A
Short Float %0.24%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA 138.87
EPS(TTM)-25.61
EYN/A
EPS(NY)-12.33
Fwd EYN/A
FCF(TTM)-4.93
FCFYN/A
OCF(TTM)-4.52
OCFYN/A
SpS19.36
BVpS26.73
TBVpS26.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.72%
ROE -29.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.71%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 4.88
Debt/FCF N/A
Debt/EBITDA 131.27
Cap/Depr 7.89%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -2
F-Score4
WACC4.63%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.48%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN STRATEGIC INVESTM-A / NYC FAQ

What is the ChartMill fundamental rating of AMERICAN STRATEGIC INVESTM-A (NYC) stock?

ChartMill assigns a fundamental rating of 0 / 10 to NYC.


What is the valuation status of AMERICAN STRATEGIC INVESTM-A (NYC) stock?

ChartMill assigns a valuation rating of 0 / 10 to AMERICAN STRATEGIC INVESTM-A (NYC). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN STRATEGIC INVESTM-A?

AMERICAN STRATEGIC INVESTM-A (NYC) has a profitability rating of 0 / 10.


Can you provide the financial health for NYC stock?

The financial health rating of AMERICAN STRATEGIC INVESTM-A (NYC) is 0 / 10.


What is the earnings growth outlook for AMERICAN STRATEGIC INVESTM-A?

The Earnings per Share (EPS) of AMERICAN STRATEGIC INVESTM-A (NYC) is expected to grow by 2.11% in the next year.